Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Effects of Enavogliflozin on Outcomes in Patients With Functional Tricuspid Regurgitation and Heart Failure With Preserved Left Ventricular Ejection Fraction

NCT06027307 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT06027307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06027307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Effects of Enavogliflozin on Outcomes in Patients With Functional Tricuspid Regurgitation and Heart Failure With Preserved Left Ventricular Ejection Fraction
Lead sponsor
Asan Medical Center
Phase
Phase 3
Overall status
Active, not recruiting
Start date
October 25, 2023
Completion date
August 31, 2027
Enrollment
541 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with preserved ejection fraction, tricuspid regurgitation